Flow cytometric evaluation of pregnancy-induced anti-donor immunization

Transplant Proc. 2012 Jul-Aug;44(6):1656-9. doi: 10.1016/j.transproceed.2012.04.027.

Abstract

Background: Living donor kidneys from spouses and children (from offspring to parents) are currently considered to be important organ sources. However, pregnancy-induced alloimmunization may provoke acute rejection episodes after kidney transplantation. being flow cytometry cross-match (FCXM) we studied donor-specific antibodies (DSAs) in the sera of recipients planned for living kidney transplantation from their spouse or children. When the FCXM was positive, we confirmed the existence of anti-human leukocyte antigen (HLA) antibodies using flow cytometry panel-reactive antibody (flow-PRA).

Patients and methods: Between March 2005 and November 2010, we tested 85 pretransplantation sera from renal transplant recipients for DSAs. The recipients included 37 wives (group I) and 48 husbands (group II). FCXM-positive sera were tested using a flow-PRA screening method using HLA class I and class II antigen-coated beads. The mean recipient age was 48.1 ± 9.8 (range, 28-69) years and the mean donor age was 45.1 ± 11.1 (range, 23-69 years).

Results: Among group I were 18 (48.6%) FCXM-positive cross-matches; for group II, 5 (10.4%) cases (P = .001). Sensitized patients were 37.9% FCXM-positive, whereas nonsensitized patients were 3.7% positive (P = .001). FCXM-positive patients were re-evaluated for anti-HLA antibodies using flow-PRA. Seventeen of 18 group I tests (94.4%) were FCXM-positive, whereas 3 of 5 (60%) were positive among group II.

Conclusions: We concluded that flow cytometry-based cross-match and PRA techniques can be used to detect anti-HLA antibodies using spousal or children donors for kidney transplantation.

MeSH terms

  • Adult
  • Adult Children
  • Aged
  • Chi-Square Distribution
  • Donor Selection
  • Female
  • Flow Cytometry*
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • HLA Antigens / immunology*
  • Histocompatibility Testing / methods*
  • Histocompatibility*
  • Humans
  • Immunity, Humoral
  • Isoantibodies / blood*
  • Kidney Transplantation / immunology*
  • Living Donors*
  • Maternal-Fetal Exchange / immunology*
  • Middle Aged
  • Predictive Value of Tests
  • Pregnancy
  • Spouses
  • Treatment Outcome
  • Turkey
  • Young Adult

Substances

  • HLA Antigens
  • Isoantibodies